欧州連合 - エストニア語 - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic kasvajad, kastreerimine-vastupidavad - antineoplastilised ained - treatment of adult patients with prostate cancer.

欧州連合 - エストニア語 - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

欧州連合 - エストニア語 - EMA (European Medicines Agency)

mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

欧州連合 - エストニア語 - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

欧州連合 - エストニア語 - EMA (European Medicines Agency)

janssen-cilag international n.v. - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - zytiga tähistab prednisoon või prednisoloon:ravi metastaatilise kastreerimine vastupidav eesnäärme vähk on täiskasvanud mehed, kes on asümptomaatilised või kergelt sümptomaatiline pärast rikke androgeeni puudust ravi kellele keemiaravi ei ole veel kliiniliselt indicatedthe ravi metastaatilise kastreerimine vastupidav eesnäärme vähk on täiskasvanud mehed, kelle haigus on edasi arenenud, või pärast docetaxel põhinevat keemiaravi raviskeemi.

エストニア - エストニア語 - Ravimiamet

zentiva k.s. - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk

エストニア - エストニア語 - Ravimiamet

viasana uab - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk

エストニア - エストニア語 - Ravimiamet

g.l. pharma gmbh - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk

エストニア - エストニア語 - Ravimiamet

norameda uab - abirateroon - õhukese polümeerikattega tablett - 500mg 60tk; 500mg 56tk

エストニア - エストニア語 - Ravimiamet

gedeon richter plc. - abirateroon - õhukese polümeerikattega tablett - 500mg 60tk